MACSF

COMMUNIQUÉS West-GlobeNewswire

Ahsan Ashraf Joins Jaylen Brown as Hapbee Investor, Executive and Board Member
27/06/2025
Hapbee Expands Board by Three Members with Senior Leaders in Tech, Legal, and Finance as it Enters Next Phase of Growth; Announces Revocation of MCTO MONTREAL, June 27, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc [...]
Informations sur le nombre total de droits de vote et d'actions
27/06/2025
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 27 juin 2025, 22:30h CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 [...]
Information on the total number of voting rights and shares
27/06/2025
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 27, 2025 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]
INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
27/06/2025
Boca Raton, Florida, June 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has entered into securities purchase [...]
Jupiter Neurosciences Unveils Nugevia™ GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Science
27/06/2025
GLO targets the growing ”beauty-from-within” market with scientifically proven cellular defense and skin vitality benefits Jupiter, Florida, June 27, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS [...]
Calidi Biotherapeutics Announces Shareholder Letter from CEO
27/06/2025
SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies [...]
Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology
27/06/2025
Patent supports the Company’s broader mission to advance minimally invasive, nerve-focused treatments across high-need indications Strengthens strategic position in a multi-billion-dollar market opportunity and expands [...]
CorMedix Inc. Announces Pricing of Public Offering of Common Stock
27/06/2025
BERKELEY HEIGHTS, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]
Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
27/06/2025
Upfront Gross Proceeds of $5.0 Million, with Up to Approximately $9.8 Million of Additional Gross Proceeds Assuming the Cash Exercise in Full of Private Placement Warrants WATERTOWN, Mass., June 27, 2025 (GLOBE NEWSWIRE [...]
Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome
27/06/2025
Phase 3 Aspire study enrollment on track to complete in 2025 Aurora study to evaluate GTX-102 in other Angelman syndrome genotypes and ages expected to initiate later this year NOVATO, Calif., June 27, 2025 (GLOBE [...]
Results of Annual General Meeting
27/06/2025
June 27, 2023 Biodexa Pharmaceuticals PLC (“ Biodexa ” or the “ Company ”) Results of Annual General Meeting Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline [...]
Helius Medical Technologies Announces Reverse Stock Split
27/06/2025
NEWTOWN, Pa., June 27, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for [...]
VigRX Organic Bio Maca Supplement: Experts Discuss Science Behind Beginner’s Guide to Choose Best Maca Root Supplement For Men & Women
27/06/2025
Discover why VigRX Organic Bio Maca is being recognized in 2025 as the best maca root supplement for men and women. Explore its energy, mood, and hormonal balance benefits. Limassol, Cyprus, June 27, 2025 (GLOBE [...]
Kratom Brand, Happy Go Leafy Announces 2025 Product Line Featuring New Strains for Pain Relief, Energy, and Mood Enhancement
27/06/2025
Check out Happy Go Leafy’s new 2025 Kratom strains offering pain relief, energy, and mood enhancement. Miami, Florida, June 27, 2025 (GLOBE NEWSWIRE) -- Kratom, a tropical tree native to Southeast Asia, has been gaining [...]
Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market
27/06/2025
Vancouver, Canada, June 27, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM
27/06/2025
NOGALES, Ariz., June 27, 2025 (GLOBE NEWSWIRE) -- – Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]
Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement
27/06/2025
FREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), an emerging leader in the development of non-opioid pain treatment therapeutics, [...]
Safety Shot Completes Acquisition of Yerbae Brands Corp.
27/06/2025
SCOTTSDALE, Ariz., June 27, 2025 (GLOBE NEWSWIRE) -- Yerbaé Brands Corp . (TSX-V: YERB.U; OTCQX: YERBF) (“ Yerbaé ”), a plant-based energy beverage company, and Safety Shot, Inc. (Nasdaq: SHOT) (“ SHOT ”, “ Safety Shot [...]
New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA
27/06/2025
New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg SPINRAZA ® ( [...]

Pages